Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TRIM23 |
| Upstream (Parents) |
|---|
| (<<) ENPEP → TRIM23 |
| (<<) MAN1A1 → TRIM23 |
| (<<) NCOA2 → TRIM23 |
| (<<) LMAN1 → TRIM23 |
| (<<) KLF11 → TRIM23 |
| Downstream (Children) |
|---|
| TRIM23 → TAF9B (>>) |
| TRIM23 → NEAT1 (>>) |
| TRIM23 → BARX2 (>>) |
| TRIM23 → DEPDC5 (>>) |
| TRIM23 → EWSR1 (>>) |
| TRIM23 → WASL (>>) |
| TRIM23 → MGAT2 (>>) |
| TRIM23 → SLC22A8 (>>) |
| TRIM23 → DIAPH2 (>>) |
| TRIM23 → TGM5 (>>) |
| TRIM23 → IMPG2 (>>) |
| TRIM23 → THAP9 (>>) |
| TRIM23 → GUSBP3///SMA5///SMA4 (>>) |
| TRIM23 → HNMT (>>) |
| TRIM23 → NEUROD6 (>>) |
| TRIM23 → AFF1 (>>) |
